Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Research Institute of Pancreatic Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ann Surg Oncol. 2022 Mar;29(3):1533-1539. doi: 10.1245/s10434-021-10797-2. Epub 2021 Oct 7.
The aim of this study was to clarify the minimum number of examined lymph nodes (MNELNs) required to ensure the quality of lymph node detection and its impact on long-term survival in distal pancreatectomy for pancreatic ductal adenocarcinoma.
Clinicopathological characteristics and survival data of patients with resectable pancreatic cancer who underwent distal pancreatectomy between 2004 and 2017 were collected from the Surveillance, Epidemiology, and End Results database. The associations between the number of examined lymph nodes (ELNs) and number of positive lymph nodes (PLNs), stage migration, and overall survival were investigated through adjusted multivariate models with locally weighted scatterplot smoothing smoothing fitting curves and estimation of the structural breakpoints. Kaplan-Meier survival analysis and X-tile software were used to identify the ideal cut-off value for ELNs.
In total, 2610 consecutive patients who underwent distal pancreatectomy between 2004 and 2017 were included in this study. The optimal ELN count according to the associations between the number of ELNs and number of PLNs, odds ratio for stage migration, or hazard ratio for overall survival were 19, 17, and 19, respectively. Furthermore, the optimal division of ELN count for maximum overall survival was divided into three populations (ELN ≤ 8, ELN 9-18, ELN ≥ 19) based on X-tile software.
A minimal count of 19 lymph nodes was demanded to guarantee the quality of lymph node examination in patients with distal pancreatectomy. Long-term survival could be delimited by MNELNs. A sufficient number of ELNs could improve the accuracy of cancer staging and reflect a better overall survival.
本研究旨在明确在胰体尾切除术治疗胰腺导管腺癌中,为确保淋巴结检出质量和长期生存所需的最小淋巴结检查数目(MNELNs)。
从监测、流行病学和最终结果数据库中收集了 2004 年至 2017 年间接受胰体尾切除术的可切除胰腺癌患者的临床病理特征和生存数据。通过局部加权散点平滑拟合曲线和结构断点估计的调整多变量模型,研究了检查的淋巴结数目(ELNs)与阳性淋巴结数目(PLNs)、分期迁移和总生存之间的关系。Kaplan-Meier 生存分析和 X-tile 软件用于确定 ELNs 的理想截断值。
共纳入 2004 年至 2017 年间接受胰体尾切除术的 2610 例连续患者。根据 ELNs 与 PLNs 数量、分期迁移比值比或总生存风险比之间的关系,最佳 ELN 计数分别为 19、17 和 19。此外,根据 X-tile 软件,ELN 计数的最佳划分(ELN≤8、ELN 9-18、ELN≥19)可最大限度地提高总生存。
在胰体尾切除术患者中,为保证淋巴结检查质量,需要至少检查 19 个淋巴结。MNELNs 可限制长期生存。足够数量的 ELNs 可以提高癌症分期的准确性并反映更好的总体生存。